Risk of recurrent venous thromboembolism in patients with the factor V Leiden (FVR506Q) mutation: effect of warfarin and prediction by precipitating factors. East Anglian Thrombophilia Study Group - Baglin,C.; Brown,K.; Luddington,R.; Baglin,T. (Br J Haematol, 1998)